Octapharma adds track and trace solution to Werum's PAS-X

22 October 2014

Octapharma, an independent manufacturer of human protein products, has added the PAS-X Track & Trace Serialisation Aggregation solution to Werum's PAS-X at its production site in Vienna, Austria.


In a first step, PAS-X Track & Trace will be operated in the packaging area for the Chinese market. The serialisation data provided by the Chinese authorities is loaded and the used data is reported back. PAS-X Track & Trace is interfaced to the existing PAS-X and exchanges order and stock data with the MES.

Octapharma's core business is the development, production and sale of human proteins from human plasma and human cell-lines. Patients in over 100 countries are treated with products in the areas of haematology, immunotherapy and critical care. Octapharma owns five state-of-the-art production facilities in Austria, France, Germany, Sweden and Mexico.

It is intended to install Werum's PAS-X Track & Trace at further packaging lines for different target countries in the Vienna site.



Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.